|
STAFF DIRECTORY In addition to seeing patients, physicians at the Center for Parkinson's Disease and Movement Disorders are actively involved research to advance the forefront of knowledge on these challenging diseases. They also teach the next generation of physicians at the University of Chicago Pritzker School of Medicine. 
Un Jung Kang, MD Dr. Kang is an expert in the diagnosis and treatment of neurodegenerative disorders that manifest abnormal involuntary movements, such as Parkinson's disease, Huntington's disease, torsion dystonia, tics, tremor, and others. His clinical practice includes the use of botulinum toxin for various movement disorders. He participates in a national genetic study and therapeutic trials of new medications for Parkinson's disease. Dr. Kang is also interested in understanding the mechanism of neurodegenerative disorders and exploring new therapeutic modalities for brain repair through laboratory investigation. Further details of his research can be found on the Department of Neurology website. Dr. Kang received his MD degree from Johns Hopkins University and trained for both neurology residency and fellowship in Parkinson's disease and movement disorders at Columbia Presbyterian Medical Center, New York. Dr. Kang is board certified in neurology by the American Board of Psychiatry and Neurology. He is a fellow of American Academy of Neurology, a member of American Neurological Association and Movement Disorder Society. His awards include Parkinson's Disease Foundation & United Parkinson Foundation Joint Junior Faculty Award and National Parkinson Foundation Richard E. Heikkila Research Scholar Award. He has served on review panels for National Institute of Health, Veterans Administration and on the Scientific Advisory Board for Dystonia Medical Research Foundation. View a PDF of "New Treatment Options in Parkinson's Disease" an article by Dr. Kang that appeared in Clinical Comment, the Hospitals' newsletter for physicians.
Richard Penn, MD Dr. Penn has practiced neurosurgery in Chicago for 28 years. He is well known for his research and clinical work in drug delivery to the nervous system and for surgical treatments for movement disorders. He pioneered the use of implanted drug pumps to deliver medications directly to the spinal cord, implanting the first programmable pump for cancer pain and developing a new highly successful medicine for spasticity. He also has contributed to the treatment of movement disorders with early studies on neuro-transplantation for Parkinson's disease and Huntington's disease. He was one of the first in the United States to use deep brain stimulation for tremor and has extensive experience with stimulation of other brain sites to relieve bradykinesia and dystonia. Dr. Penn will be continuing his experimental and clinical work in these neuro-restorative areas at the University of Chicago, as well as caring for patients with other neurosurgical problems. View a PDF of "New Treatments for Parkinson's Disease" an article written by Dr. Penn for Clinical Comment, the Hospitals' newsletter for physicians. |